课题基金 / 基金详情

KIR AND MHC CLASS I IMMUNOGENETICS IN SIV INFECTION

KIR AND MHC CLASS I IMMUNOGENETICS IN SIV INFECTION
SIV 感染中的 KIR 和 MHC I 类免疫遗传学
批准号:
8357992
负责人:
David T Evans
金额:
$21.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

David T Evans的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Genetic evidence indicates that KIR and HLA class I polymorphisms play an important role in determining the rate of disease progression in HIV-1 infected individuals. However, the immunological mechanisms underlying these observations are poorly understood. We recently identified Mamu-A1*00201 (Mamu-A*02), a common MHC class I molecule in the rhesus macaque, as a ligand for Mamu-KIR3DL05. Using KIR- and MHC class I-defined animals, experiments can now be designed to examine the role of this KIR-MHC class I interaction in the regulation of NK cell responses to SIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
  • 批准号:
    10403162
  • 项目类别:
  • 资助金额:
    $44.11万
  • 财政年份:
    2021
  • 负责人:
    David T Evans
  • 依托单位:
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
  • 批准号:
    10591883
  • 项目类别:
  • 资助金额:
    $45.09万
  • 财政年份:
    2021
  • 负责人:
    David T Evans
  • 依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
  • 批准号:
    10425358
  • 项目类别:
  • 资助金额:
    $70.77万
  • 财政年份:
    2020
  • 负责人:
    David T Evans
  • 依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
  • 批准号:
    10082732
  • 项目类别:
  • 资助金额:
    $45.44万
  • 财政年份:
    2020
  • 负责人:
    David T Evans
  • 依托单位:
海外基金